Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2014
12/04/2014US20140356320 Polyoma virus jc peptides and proteins in vaccination and diagnostic applications
12/04/2014US20140356281 DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1 and/or IL-17
12/02/2014US8901283 Anti-NKG2A antibodies and uses thereof
12/02/2014US8901281 ILT3 binding molecules and uses therefor
12/02/2014US8901280 Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same
12/02/2014US8901279 Humanized antibodies with anti-tumor activity
12/02/2014US8901278 Pharmaceutical antibody compositions with resistance to soluble CEA
12/02/2014US8901167 Product and process for inhibition of biofilm development
12/02/2014US8901099 Method for immunizing animal, composition for immunization, method for producing antibody, method for producing hybridoma, and method for producing monoclonal antibody
12/02/2014US8901093 Custom vectors for treating and preventing pancreatic cancer
12/02/2014US8901086 Compositions including triciribine and methods of use thereof
12/02/2014US8901082 Immunity-inducing agent and method for detection of cancer
12/02/2014US8900826 Glycoprotein synthesis and remodeling by enzymatic transglycosylation
12/02/2014US8900825 Immunogenic proteins of Leptospira
12/02/2014US8900818 Recombinant antigen for diagnosis and prevention of murine typhus
12/02/2014US8900806 Antibody preparations
12/02/2014US8900639 Process for obtaining a rabbit skin comprising biological active substances
12/02/2014US8900623 Sticky soft gel for treating poultry
12/02/2014US8900600 Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapy
12/02/2014US8900599 Conjugates of Plasmodium falciparum surface proteins as malaria vaccines
12/02/2014US8900598 Multicomponent or monocomponent vaccine to be used against Chagas disease, pharmaceutical compositions containing them, procedure for the obtention of immunogen of said vaccines, and nucleic acid used in said procedure
12/02/2014US8900596 Physicochemical (PCP) based consensus sequences and uses thereof
12/02/2014US8900595 Filovirus vectors and noninfectious filovirus-based particles
12/02/2014US8900594 Oral recombinant Helicobacter pylori vaccine and preparing method thereof
12/02/2014US8900592 Protein constructs designed for targeting and lysis of cells
12/02/2014US8900591 Vaccines comprising mutant GPCRs with increased conformational stability relative to parent receptors
12/02/2014US8900590 Anti-hemagglutinin antibody compositions and methods of use thereof
12/02/2014US8900589 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
12/02/2014US8900588 Methods for treating breast cancer
12/02/2014US8900587 Antibodies to human programmed death receptor PD-1
12/02/2014US8900586 Antibody that binds domain 2 of ICAM-1 and methods of treatment
12/02/2014US8900585 Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection
12/02/2014US8900584 Human CDR-grafted antibody and antibody fragment thereof
12/02/2014US8900583 Methods for treatment of brain injury utilizing biologics
12/02/2014US8900582 Deimmunized anti c-Met humanized antibodies and uses thereof
12/02/2014US8900579 Siglec-15 antibodies in treating bone loss-related disease
12/02/2014US8900578 Anti-IL-TIF antibodies
12/02/2014US8900577 Immunoglobulin formulation and method of preparation thereof
12/02/2014US8900564 Vaccine composition comprising an antigen and a peptide having adjuvant properties
11/2014
11/27/2014US20140351960 Artery- and vein-specific proteins and uses therefor
11/27/2014US20140348924 Particles comprising single stranded rna and double stranded rna for immunomodulation
11/27/2014US20140348906 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
11/27/2014US20140348876 Stable Aqueous Formulations of Adenovirus Vectors
11/27/2014US20140348875 Koi herpesvirus vaccine
11/27/2014US20140348874 Method for the reduction of pcv-2 in a herd of swine
11/27/2014US20140348871 Composition Comprising the Amyloid Beta 1-6 Peptide Coupled to a Virus-Like Particle and an Adjuvant
11/27/2014US20140348869 Modified meningococcal fhbp polypeptides
11/27/2014US20140348868 Compositions comprising pneumococcal antigens
11/27/2014US20140348866 Gb virus c (hepatitis g virus) for the treatment of hiv
11/27/2014US20140348860 Medical devices for collecting pathogenic cells
11/27/2014US20140348850 Method for reducing blood pressure using inhibitors of plasma kallikrein
11/27/2014US20140348847 Antibodies against human il-12
11/27/2014US20140348846 Anti-hla class-ib antibodies mimic immunoreactivity and immunomodulatory functions of intravenous immunoglobulin (ivig) useful as therapeutic ivig mimetics and methods of their use
11/27/2014US20140348844 Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficile
11/27/2014US20140348836 Anti-cd40 antibodies, uses and methods
11/27/2014US20140348835 Anti-dll4/vegf dual variable domain immunoglobulin and uses thereof
11/27/2014US20140348834 Il-17 binding proteins
11/27/2014US20140348830 Interleukin-6 receptor binding polypeptides
11/27/2014US20140348829 Felinized Antibodies and Methods of Treating Retroviral Infections in Felines
11/27/2014US20140348827 Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
11/27/2014US20140348824 Predictive biomarker of survival in the treatment of renal cell carcinoma
11/27/2014US20140348823 Histone Deacetylase (HDAC) Inhibitors for the Treatment of Cancer
11/27/2014US20140348822 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated DIseases
11/27/2014US20140348821 Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer
11/27/2014US20140348819 Methods of Treating Cancer
11/27/2014US20140348786 Beta-mannosylceramide and stimulation of nkt cell anti-tumor immunity
11/27/2014US20140348785 Neutralizing gp41 antibodies and their use
11/27/2014US20140348784 Compositions and methods for treatment of angiogenesis in pathological lesions
11/27/2014US20140348783 Vaccine immunotherapy for immune suppressed patients
11/27/2014US20140348782 Vaccine immunotherapy for immune suppressed patients
11/27/2014US20140348781 Conjugates of gm-csf and il-9, compositions and methods related thereto
11/25/2014US8895724 Multivalent pneumococcal polysaccharide-protein conjugate composition
11/25/2014US8895714 Biological products
11/25/2014US8895709 Isolation and purification of antibodies using protein A affinity chromatography
11/25/2014US8895706 Chromatography matrices including novel Staphylococcus aureus protein A based ligands
11/25/2014US8895705 Antibodies against a proliferating inducing ligand (APRIL) and methods of use thereof
11/25/2014US8895694 Glucagon-Like Peptide-1 derivatives and their pharmaceutical use
11/25/2014US8895629 Circulation of components during homogenization of emulsions
11/25/2014US8895540 Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
11/25/2014US8895514 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
11/25/2014US8895502 β2-glycoprotein I peptide inhibitors
11/25/2014US8895501 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
11/25/2014US8895286 Attenuated pestiviruses
11/25/2014US8895266 Antibody composition-producing cell
11/25/2014US8895263 Methods for suppressing toll-like receptor activity
11/25/2014US8895257 Proteins used for the diagnosis of lyme borreliosis
11/25/2014US8895242 Single molecule nucleic acid nanoparticles
11/25/2014US8895237 Enhancing of hepatitis B virus vaccine and its gene
11/25/2014US8895067 Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer
11/25/2014US8895049 Extended release biodegradable ocular implants
11/25/2014US8895031 Reagents and methods for cancer treatment and prevention
11/25/2014US8895030 Interaction of Moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
11/25/2014US8895029 Compositions and methods for vaccinating cattle
11/25/2014US8895027 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
11/25/2014US8895026 Attenuated pestivirus
11/25/2014US8895025 Infectious cDNA of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/25/2014US8895024 Multivalent pneumococcal polysaccharide-protein conjugate composition
11/25/2014US8895023 Nanoparticles for providing immune responses against infectious agents
11/25/2014US8895022 Methods of use of soluble CD24 for therapy of rheumatoid arthritis
11/25/2014US8895021 Sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 1823